Vanguard Fiduciary Trust
TRAW icon

Vanguard Fiduciary Trust’s Traws Pharma TRAW Stock Holding History

Vanguard Fiduciary Trust’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46K Buy
54,511
+22,707
+71% +$31.3K ﹤0.01% 3885
2026
Q1 		$58.2K Buy
+31,804
New +$59.8K ﹤0.01% 3804

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vanguard Fiduciary Trust's TRAW Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Traws Pharma (TRAW) stake by 71% in Q2 2026, buying an estimated $31.3K and bringing the position to 54,511 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #3885.

Vanguard Fiduciary Trust first reported a position in TRAW in Q1 2026 and has held it in 2 quarters since. The position peaked at $58.2K in Q1 2026. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Vanguard Fiduciary Trust held 54,511 shares of Traws Pharma worth $46K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 22,707 Traws Pharma shares in Q2 2026, an estimated $31.3K.
  • Traws Pharma made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3885 holding.
  • Vanguard Fiduciary Trust first reported a position in Traws Pharma in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Traws Pharma position peaked at $58.2K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.